// App-Quantinova.ai

2285 : Aggressive Smoldering Curative Approach Evaluating Novel Therapies (ASCENT): A Phase 2 Trial of Induction, Consolidation and Maintenance in Subjects with High Risk Smoldering Multiple Myeloma (SMM): Initial Analysis of Safety Data

Researchers

Presenter

  • Shaji K. Kumar

Principal Investigators

  • Al-Ola Abdallah

  • Ashraf Z. Badros

  • Betsy Laplant

  • Binod Dhakal

  • Melissa Alsina

  • Rafat Abonour

  • Cara A. Rosenbaum

  • William I Bensinger

  • Manisha Bhutani

  • Andrzej Jakubowiak

  • Erica Kim

  • Brian G.M. Durie

Medical Centers

  • Mayo Clinic, Division of hematology, Rochester, MN

  • University of Kansas Medical Center, Westwood, KS

  • The University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland Medical Center, Baltimore, MD

  • Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN

  • The Medical College of Wisconsin, Milwaukee, WI

  • Department of Blood & Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Ctr. Hematologic Malignancies Program, Tampa, FL

  • Indiana Cancer Pavillion, Indianapolis, IN

  • Division of Hematology & Medical Oncology, Weill Cornell Medical College & New York-Presbyterian Hospital, New York, NY

  • Center for Blood Disorders and Stem Cell Transplantation, Swedish Cancer Institute,Seattle,Estados Unidos

  • Levine Cancer Institute, Charlotte, SC

  • The University of Chicago Medical Center, Chicago, IL

  • Trevie Research, Los Angeles

  • Cedars-Sinai Outpatient Cancer Center, Los Angeles, CA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Smoldering myeloma

  • Venous thrombosis

  • Multiple Myeloma

Biomarkers

  • N/A

Drug/Treatment

  • Dexamethasone

  • Dekpak 13 Day Taperpak

  • Lenalidomide

  • carfilzomib Intravenous

  • daratumumab Intravenous

Outcome

  • N/A

Study Design

  • N/A

Phase

  • II

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved